Duke University Cancer Institute — Durham, North Carolina

Duke University Cancer Institute is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Cancer Institute has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Melanoma, Advanced Melanoma, Metastatic Melanoma.

Sponsors: Regeneron Pharmaceuticals, Immuneering Corporation.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Cancer Institute?

Duke University Cancer Institute has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Cancer Institute conducted?

Duke University Cancer Institute has 3 clinical trials on record, with 1 currently active. Their work covers Melanoma, Advanced Melanoma, Metastatic Melanoma.

Is Duke University Cancer Institute accredited by Crixeo Health?

Duke University Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.